T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis
- PMID: 21448952
- PMCID: PMC3130738
- DOI: 10.1002/jmri.22514
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis
Abstract
Purpose: To determine the precision and accuracy of hepatic fat-fraction measured with a chemical shift-based MRI fat-water separation method, using single-voxel MR spectroscopy (MRS) as a reference standard.
Materials and methods: In 42 patients, two repeated measurements were made using a T(1) -independent, T 2*-corrected chemical shift-based fat-water separation method with multi-peak spectral modeling of fat, and T(2) -corrected single voxel MR spectroscopy. Precision was assessed through calculation of Bland-Altman plots and concordance correlation intervals. Accuracy was assessed through linear regression between MRI and MRS. Sensitivity and specificity of MRI fat-fractions for diagnosis of steatosis using MRS as a reference standard were also calculated.
Results: Statistical analysis demonstrated excellent precision of MRI and MRS fat-fractions, indicated by 95% confidence intervals (units of absolute percent) of [-2.66%,2.64%] for single MRI ROI measurements, [-0.81%,0.80%] for averaged MRI ROI, and [-2.70%,2.87%] for single-voxel MRS. Linear regression between MRI and MRS indicated that the MRI method is highly accurate. Sensitivity and specificity for detection of steatosis using averaged MRI ROI were 100% and 94%, respectively. The relationship between hepatic fat-fraction and body mass index was examined.
Conclusion: Fat-fraction measured with T(1) -independent T 2*-corrected MRI and multi-peak spectral modeling of fat is a highly precise and accurate method of quantifying hepatic steatosis.
Copyright © 2011 Wiley-Liss, Inc.
Figures








Similar articles
-
Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling.J Magn Reson Imaging. 2009 Jun;29(6):1332-9. doi: 10.1002/jmri.21751. J Magn Reson Imaging. 2009. PMID: 19472390 Free PMC article.
-
Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.Eur J Radiol. 2015 Aug;84(8):1452-1458. doi: 10.1016/j.ejrad.2015.05.001. Epub 2015 May 14. Eur J Radiol. 2015. PMID: 26047820
-
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.Radiology. 2011 Mar;258(3):767-75. doi: 10.1148/radiol.10100708. Epub 2011 Jan 19. Radiology. 2011. PMID: 21248233 Free PMC article.
-
Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.J Magn Reson Imaging. 2014 Jun;39(6):1494-501. doi: 10.1002/jmri.24289. Epub 2013 Oct 10. J Magn Reson Imaging. 2014. PMID: 24123655 Free PMC article.
-
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.Radiology. 2018 Feb;286(2):486-498. doi: 10.1148/radiol.2017170550. Epub 2017 Sep 11. Radiology. 2018. PMID: 28892458 Free PMC article. Review.
Cited by
-
In vivo triglyceride composition of abdominal adipose tissue measured by 1 H MRS at 3T.J Magn Reson Imaging. 2017 May;45(5):1455-1463. doi: 10.1002/jmri.25453. Epub 2016 Aug 29. J Magn Reson Imaging. 2017. PMID: 27571403 Free PMC article.
-
Comparison of R2* correction methods for accurate fat quantification in fatty liver.J Magn Reson Imaging. 2013 Feb;37(2):414-22. doi: 10.1002/jmri.23835. Epub 2012 Nov 16. J Magn Reson Imaging. 2013. PMID: 23165934 Free PMC article.
-
Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2013 Mar;37(6):630-9. doi: 10.1111/apt.12237. Epub 2013 Feb 5. Aliment Pharmacol Ther. 2013. PMID: 23383649 Free PMC article.
-
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.Aliment Pharmacol Ther. 2012 Jul;36(1):22-9. doi: 10.1111/j.1365-2036.2012.05121.x. Epub 2012 May 3. Aliment Pharmacol Ther. 2012. PMID: 22554256 Free PMC article.
-
Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.Magn Reson Med. 2014 Jul;72(1):8-19. doi: 10.1002/mrm.24917. Epub 2013 Sep 4. Magn Reson Med. 2014. PMID: 24006208 Free PMC article.
References
-
- Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005;50:171–180. - PubMed
-
- Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2004;8:861–879. ix. - PubMed
-
- Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. - PubMed
-
- Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450–455. - PubMed
-
- Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3–20. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources